Abstract. The purpose of the present study was to identify genetic variants which confer susceptibility to chronic kidney disease (CKD) in high-or low-risk subjects defined by conventional risk factors separately. The study population comprised 2828 Japanese individuals, including 434 subjects with CKD [estimated glomerular filtration rate (eGFR) <60 ml/min/1.73 m 2 ] and 2394 controls (eGFR ≥60 ml/min/ 1.73 m 2 ). The 1012 high-risk subjects had both hypertension and diabetes mellitus, and the 1816 low-risk subjects had none of these conditions. The genotypes for 296 polymorphisms of 202 candidate genes were determined. The Chi-square test, multivariable logistic regression analysis with adjustment for covariates, as well as a stepwise forward selection procedure revealed that ten different polymorphisms were associated (P<0.05) with the prevalence of CKD in high-or low-risk subjects: the -519A→G polymorphism of MMP1, the 1061A→G (Ile405Val) polymorphism of CETP, the A→G (Lys45Glu) polymorphism of MMP3, the -219G→T polymorphism of APOE, the A→G (Ile1205Val) polymorphism of COL3A1, the -863C→A polymorphism of TNF, and the 1454C→G (Leu125Val) polymorphism of PECAM1 in high-risk subjects; and the 1167C→T (Asn389Asn) polymorphism of TGFBR2, the 2386A→G (Ile796Val) polymorphism of SCAP, and the TAAA→del polymorphism of PDE4D in low-risk subjects. Among these polymorphisms, the -519A→G polymorphism of MMP1 and the 1167C→T (Asn389Asn) polymorphism of TGFBR2 were most significantly associated with CKD in high-or low-risk individuals, respectively. These results suggest that polymorphisms associated with CKD may differ among high-or low-risk subjects. Stratification of subjects according to conventional risk factors may thus be important for personalized prevention of CKD based on genetic information.
Introduction
Chronic kidney disease (CKD) has been recognized as a global public health problem; individuals with CKD are at increased risk not only for end-stage renal disease (ESRD) but also for a poor cardiovascular outcome and premature death (1, 2) . It is usually associated with conventional risk factors, including hypertension and diabetes mellitus (3) (4) (5) (6) . In the large percentage of CKD cases, which occur in the setting of hypertension or diabetes mellitus, arteriosclerosis seems to be a major pathogenic mechanism (7) . However, susceptibility to CKD varies considerably among individuals with known risk factors, suggesting a role for genetic factors other than those that influence high blood pressure, hyperglycemia, or other conventional risk factors for arteriosclerosis. This has been demonstrated in animal models (8) and suggested in humans by the disproportionate burden of ESRD among black individuals which may not be explained by greater prevalence or severity of hypertension or diabetes mellitus (9) . In general, individuals with hypertension and diabetes mellitus and those with none of these factors are considered at high-or low-risk, respectively, for development of CKD. It is thus important to identify genes that confer susceptibility to CKD in high-or low-risk individuals independently. Disease prevention is an important strategy for reducing the overall burden of CKD and ESRD, and the identification of markers for disease risk Association of gene polymorphisms with chronic kidney disease in high-or low-risk subjects defined by conventional risk factors is key both for risk prediction and for potential intervention to reduce the chance of future cardiovascular events (10). Although genetic linkage analyses (11) and association studies (12) (13) (14) have implicated several loci and candidate genes in predisposition to CKD, the genes that contribute to genetic susceptibility to CKD in high-or low-risk subjects remain largely unknown. In addition, given the ethnic differences in lifestyle and environmental factors as well as in genetic background, it is important to examine genetic variants related to CKD in high-or low-risk individuals of each ethnic group. We now performed an association study for 296 polymorphisms of 202 candidate genes and CKD in 2828 Japanese individuals in the absence or presence of hypertension and diabetes mellitus. The purpose of the present study was to identify genetic variants that confer susceptibility to CKD in high-or low-risk subjects independently and thereby to assess the genetic risk of CKD in such individuals separately.
Materials and methods
Study population. The study population comprised 2828 unrelated Japanese individuals (1535 men, 1293 women) who either visited outpatient clinics of or were admitted to one of the participating hospitals (Gifu Prefectural General Medical Center and Gifu Prefectural Tajimi Hospital in Gifu Prefecture, Japan; and Hirosaki University Hospital, Reimeikyo Rehabilitation Hospital, and Hirosaki Stroke Center in Aomori Prefecture, Japan) between October 2002 and March 2008 because of various symptoms or for an annual health checkup, or who were recruited to a population-based prospective cohort study of aging and age-related diseases in Gunma Prefecture and Tokyo, Japan.
Glomerular filtration rate was estimated with the use of the simplified prediction equation derived from the modified version of that described in the Modification of Diet in Renal Disease (MDRD) Study as proposed by the Japanese Society of Nephrology (15) (16) . We thus adopted the criterion of an eGFR of <60 ml min -1 1.73 m -2 for diagnosis of CKD in the present study. On the basis of this criterion, 434 subjects (263 men, 171 women) were diagnosed with CKD. The control subjects comprised 2394 individuals (1272 men, 1122 women) whose eGFR was ≥60 ml min -1 1.73 m -2 . The control subjects were recruited from community-dwelling healthy individuals or the patients who visited outpatient clinics regularly for treatment of various common diseases. Subjects with CKD and controls thus either had or did not have conventional risk factors for CKD, including hypertension (systolic blood pressure of ≥140 mmHg or diastolic blood pressure of ≥90 mmHg, or both, or taking antihypertensive medication), diabetes mellitus (fasting blood glucose of ≥6.93 mmol/l or hemoglobin A1c of ≥6.5%, or both, or taking antidiabetes medication), or hypercholesterolemia (serum total cholesterol of ≥5.72 mmol/l or taking lipidlowering medication). Among all 2828 study subjects, the 1012 individuals (668 men, 344 women) with both hypertension and diabetes mellitus were classified as high-risk subjects, and the 1816 individuals (867 men, 949 women) with none of these conditions were classified as low-risk subjects.
The Genotyping of polymorphisms. Venous blood (7 ml) was collected in tubes containing 50 mmol/l ethylenediaminetetraacetic acid (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 296 polymorphisms were determined at G&G Science (Fukushima, Japan) by a method that combines the polymerase chain reaction (PCR) and sequence-specific oligonucleotide probes with suspension array technology (Luminex, Austin, TX). Detailed genotyping methodology was described previously (17) .
Statistical analysis. Quantitative data were compared between subjects with CKD and controls in high-or low-risk subjects by the unpaired Student's t-test. Categorical data were compared by the Chi-square test. Allele frequencies were estimated by the gene counting method. In the initial screen, the genotype distributions (3 x 2) or allele frequencies (2 x 2) of each polymorphism were compared between subjects with CKD and controls in high-or low-risk subjects by the Chisquare test. Multivariable logistic regression analysis was then performed with CKD as a dependent variable and independent variables including age, gender (0, woman; 1, man), body mass index (BMI), smoking status (0, nonsmoker; 1, smoker), history of hypercholesterolemia (0, no history; 1, positive history), and genotype of each polymorphism; the P-value, odds ratio, and 95% confidence interval were calculated. Each genotype was assessed according to dominant, recessive, and additive genetic models. Additive models included the additive 1 (heterozygotes versus wild-type homozygotes) and additive 2 (variant homozygotes versus wild-type homozygotes) models, which were analyzed simultaneously with a single statistical model. We also performed a stepwise forward selection procedure to examine the effects of genotypes as well as of other covariates on CKD; each genotype was examined according to a dominant or recessive model on the basis of statistical significance in the multivariable logistic regression analysis. The P-levels for inclusion in and exclusion from the model were 0.25 and 0.1, respectively. A P-value <0.05 was considered statistically significant. Statistical significance was examined by two-sided tests performed with JMP version 6.0 software (SAS Institute, Cary, NC).
Results
Polymorphisms related to CKD in high-risk subjects. The characteristics of the 1012 high-risk subjects (668 men, 344 women) are shown in Table I . Age and systolic blood pressure were greater, whereas the percentage of smokers and blood glycosylated hemoglobin content were lower, in subjects with CKD than in controls.
Comparison of allele frequencies with the Chi-square test revealed that the -519A→G polymorphism of MMP1, the -3A→G polymorphism of APOA5, the A→G (Ile1205Val) polymorphism of COL3A1, the -219G→T polymorphism of APOE, the A→G (Lys45Glu) polymorphism of MMP3, the A→G (Tyr243Cys) polymorphism of SERPINE1, the 1454C→G (Leu125Val) polymorphism of PECAM1, the 1061A→G (Ile405Val) polymorphism of CETP, the -863C→A polymorphism of TNF, and the -1607/1G→2G polymorphism of MMP1 were significantly (P<0.05) associated with the prevalence of CKD (Table II) .
Multivariable logistic regression analysis with adjustment for age, gender, BMI, smoking status, and the prevalence of hypercholesterolemia revealed that the -519A→G polymorphism of MMP1 (dominant and additive 1 models), the -3A→G polymorphism of APOA5 (recessive and additive 2 models), the A→G (Ile1205Val) polymorphism of COL3A1 (dominant and additive 1 models), the -219G→T polymorphism of APOE (dominant, recessive, and additive 1 and 2 models), the A→G (Lys45Glu) polymorphism of MMP3 (dominant and additive 1 and 2 models), the 1454C→G (Leu125Val) polymorphism of PECAM1 (dominant and additive 2 models), the 1061A→G (Ile405Val) polymorphism of CETP (dominant and additive 1 and 2 models), the -863C→A polymorphism of TNF (dominant and additive 1 models), and the -1607/1G→2G polymorphism of MMP1 (dominant and additive 1 and 2 models) were significantly (P<0.05) associated with the prevalence of CKD (Table III) . The variant G allele of the -519A→G polymorphism of MMP1, T allele of APOE, and G allele of PECAM1 were risk factors for CKD, whereas the G allele of APOA5, G allele of COL3A1, G allele of MMP3, G allele of CETP, A allele of TNF, and 2G allele of the -1607/1G→2G polymorphism of MMP1 were protective against this condition.
A stepwise forward selection procedure was performed to examine the effects of genotypes for the nine polymorphisms associated with CKD by multivariable logistic regression Table I . Characteristics of subjects with chronic kidney disease (CKD) and controls in the present study. 
Quantitative data are means ± SD. eGFR, estimated glomerular filtration rate; HDL, high-density lipoprotein.
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women) are shown in Table I . Age, the frequency of male subjects, systolic blood pressure, blood glycosylated hemoglobin content, the prevalence of hypercholesterolemia and myocardial infarction, as well as the serum concentrations of total cholesterol and triglycerides were greater, whereas fasting plasma glucose level and the serum concentration of highdensity lipoprotein cholesterol were lower in subjects with CKD than in controls.
Comparison of allele frequencies with the Chi-square test revealed that the 1167C→T (Asn389Asn) polymorphism of TGFBR2, the 2386A→G (Ile796Val) polymorphism of SCAP, and the TAAA→del polymorphism of PDE4D were significantly (P<0.05) associated with the prevalence of CKD (Table V) .
Multivariable logistic regression analysis with adjustment for age, gender, BMI, smoking status, and the prevalence of hypercholesterolemia revealed that the 1167C→T (Asn389Asn) polymorphism of TGFBR2 (dominant and additive 1 and 2 models), the 2386A→G (Ile796Val) polymorphism of SCAP (recessive and additive 2 models), and the TAAA→del polymorphism of PDE4D (recessive and additive 2 models) were significantly (P<0.05) associated with the prevalence of CKD (Table VI) . The variant G allele of SCAP and deletion allele of PDE4D were risk factors for CKD, whereas the variant T allele of TGFBR2 was protective against this condition.
A stepwise forward selection procedure was performed to examine the effects of genotypes for the three polymorphisms associated with CKD by multivariable logistic regression analysis as well as of age, gender, BMI, smoking status, and the prevalence of hypercholesterolemia on CKD (Table VII) . Age, hypercholesterolemia, BMI, PDE4D genotype (recessive model), TGFBR2 genotype (dominant model), and SCAP genotype (recessive model) in descending order of statistical significance, were significant (P<0.05) and independent determinants of CKD.
Discussion
We examined the possible relations of 296 polymorphisms of 202 candidate genes to the prevalence of CKD in high-or Table III . Multivariable logistic regression analysis of polymorphisms related to chronic kidney disease in high-risk subjects.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, gender, BMI, smoking status, and the prevalence of hypercholesterolemia.
P-values <0.05 are shown in bold.
- Table IV . Effects of genotypes and other characteristics on the prevalence of chronic kidney disease in high-risk subjects as determined by a stepwise forward selection procedure. 
low-risk subjects separately. Our association study with three steps of analysis (Chi-square test, multivariable logistic regression analysis, and stepwise forward selection procedure) revealed that ten different polymorphisms were associated with the prevalence of CKD in high-or low-risk subjects. Among these polymorphisms, the -519A→G polymorphism of MMP1 and the 1167C→T (Asn389Asn) polymorphism of TGFBR2 were most significantly associated with CKD in high-and low-risk individuals, respectively. Matrix metallopeptidase 1 (MMP1) degrades fibrillar collagens, especially types I and III, which are resistant to most other proteinases (18) . The -519A→G polymorphism of MMP1, which is located in the promoter region of the gene, has been associated with the risk of myocardial infarction as part of a haplotype including other polymorphisms of MMP1 (19) . In addition, the G allele of this polymorphism was associated with an increased intima-media thickness of the carotid artery in a German population with hypertension (20) . We now showed that the -519A→G polymorphism of MMP1 was significantly associated with the prevalence of CKD in high-risk subjects, with the G allele representing a risk factor for this condition. Effects of this polymorphism on the development of atherosclerosis may account for its association with CKD.
Transforming growth factor, ß receptor II (TGFBR2) forms a heterodimeric complex with TGFBR1 and binds to transforming growth factor, ß 1 which is a multifunctional cytokine implicated in the pathogenesis of many forms of progressive renal disease (21) . It has been proposed that upregulation of TGFBR2 induced by high extracellular glucose may contribute to distal tubular hypertrophy in diabetic nephropathy (22) . TGFBR2 is composed of seven exons and maps to 3p22 (23) . Although the 869T→C (Leu10Pro) polymorphism of TGFBR2 was shown to be associated with diabetic nephropathy (24) , the 1167C→T (Asn389Asn) polymorphism has not previously been associated with this condition. We now showed that the 1167C→T (Asn389Asn) polymorphism of TGFBR2 was significantly associated with the prevalence of CKD in lowrisk subjects, with the T allele being protective against this condition, although the molecular mechanism underlying this association remains to be elucidated.
We found that six and two polymorphisms were also related to the prevalence of CKD in high-or low-risk subjects, respectively, with none of these polymorphisms having previously been shown to be associated with CKD. The -219G→T polymorphism of APOE was previously associated with myocardial infarction in men in France and Northern Ireland, with the T allele representing a risk factor for this condition (25) . The T allele of this polymorphism was also shown to be a risk factor for coronary heart disease in lowrisk Japanese men (26) . Although the -308G→A polymorphism of TNF (27, 28) was shown to be associated with CKD, the -863C→A polymorphism of TNF has not previously been associated with this condition. The A allele of the -863C→A polymorphism of TNF was shown to be protective against the development of coronary heart disease in Japanese men without type 2 diabetes (29) . We previously showed that the -1171/5A→6A polymorphism of MMP3 was associated with the prevalence of myocardial infarction in Japanese women (30) . The 6A allele of this polymorphism was also associated with increased intima-media thickness of the carotid artery (31) . These various observations implicate MMP3 as a candidate gene for atherosclerosis. The G→A (Gly670Arg) polymorphism of PECAM1 was associated with an increased risk of myocardial infarction in Japanese (32) , with the A allele representing a risk factor for this condition. The G allele of the 1061A→G (Ile405Val) polymorphism in CETP has been associated with an independent risk factor for coronary heart disease in white women, despite being related to the increased levels of high-density lipoprotein cholesterol (33) . EhlersDanlos syndrome type IV, the vascular type, results from mutations in COL3A1 (34) . The 2386A→G (Ile796Val) polymorphism of SCAP was associated with the serum concentrations of total cholesterol and triglycerides in response to Table V . Genotype distributions of polymorphisms related (allele frequency, P<0.05) to chronic kidney disease (CKD) in lowrisk subjects as determined by the Chi-square test. (35) . Single nucleotide polymorphisms of PDE4D were associated with increased risk of ischemic stroke in nonhypertensive subjects in a prospective study of American women over age 65 years (36) .
Our study has several limitations: i) We used an estimated glomerular filtration rate (eGFR) instead of a directly measured rate to define CKD. ii) We were not able to obtain information on the underlying renal disease or the primary cause of CKD in each subject with CKD. iii) It is possible that one or more of the polymorphisms associated with CKD in the present study are in linkage disequilibrium with other polymorphisms in the same gene or in other nearby genes that are actually responsible for the development of this condition. iv) The functional relevance of the identified polymorphisms to gene transcription or to protein structure or function was not determined in the present study. v) Given the multiple comparisons of genotypes with CKD, it is not possible to exclude completely potential statistical errors such as false positives. Our present study can thus be considered as hypothesis generating.
In conclusion, our present results suggest that polymorphisms associated with CKD may differ among high-or low-risk subjects. Stratification of subjects according to conventional risk factors may thus be important for personalized prevention of CKD based on genetic information. Validation of our findings will require their replication with independent subject panels. Table VI . Multivariable logistic regression analysis of polymorphisms related to chronic kidney disease in low-risk subjects.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, gender, BMI, smoking status, and the prevalence of hypercholesterolemia. P-values <0.05 are shown in bold.
- Table VII . Effects of genotypes and other characteristics on the prevalence of chronic kidney disease in low-risk subjects as determined by a stepwise forward selection procedure.
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